Back to Results
First PageMeta Content



Zymeworks Appoints Noel Hall to Its Board of Directors November 3rd, 2008 VANCOUVER, British Columbia, Canada – Zymeworks Inc., a privately held computational biotechnology company, today announced the appointment of N
Add to Reading List

Document Date: 2014-08-22 12:47:44


Open Document

File Size: 120,07 KB

Share Result on Facebook

City

VANCOUVER / /

Company

The Wellcome Foundation Ltd. / Abbott Laboratories Ltd. / Galenica Group / Zymeworks Inc. / Leo Laboratories Ltd. / Hill / Aspreva Pharmaceuticals / iCo Therapeutics Inc. / GlaxoSmithKline PLC / /

Country

Canada / /

Event

M&A / Employment Change / /

Facility

Zymeworks Appoints Noel Hall / Mr. Hall / London University / /

IndustryTerm

performance computing / molecular simulation technology / pharmaceutical and chemical sectors / biotechnology industry / computational biotechnology / pharmaceutical consulting practice / protein systems / biotechnology sector / chemical insights / /

Organization

London University / /

Person

Hall / Ali Tehrani / Noel Hall / /

Position

Director of Corporate Affairs for the United Kingdom and Northern Europe / Head of Global Strategic Planning / President and CEO / regional sales manager / consultant / Co-founder / President / and Director / member of the board / /

Product

ZymeCAD / /

ProvinceOrState

British Columbia / /

Region

Northern Europe / /

Technology

molecular simulation technology / biotechnology / simulation / /

URL

http /